These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6104790)

  • 61. Clinical and biochemical effects of parachlorophenylalanine in a patient with the carcinoid syndrome.
    Bax ND; Boulton AJ; Woods HF; Green AR
    Postgrad Med J; 1982 Aug; 58(682):493-5. PubMed ID: 6215640
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of novel pharmacological agents in carcinoid syndrome: case report.
    Arnold AC; Leichter SB
    Mil Med; 1977 Dec; 142(12):949-50. PubMed ID: 414163
    [No Abstract]   [Full Text] [Related]  

  • 63. Ketanserin, a 5-HT antagonist, in symptomatic treatment of carcinoid syndrome.
    Sullivan PA; O'Donovan M
    Ir J Med Sci; 1986 Dec; 155(12):436. PubMed ID: 3818255
    [No Abstract]   [Full Text] [Related]  

  • 64. Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension.
    Kasi PM
    Pancreas; 2018 Jan; 47(1):e2. PubMed ID: 29232344
    [No Abstract]   [Full Text] [Related]  

  • 65. The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.
    Beltrutti DP; Moessinger S; Varrassi G
    Curr Rev Pain; 2000; 4(1):82-90. PubMed ID: 10998719
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gastroenteropancreatic endocrine tumors.
    Weil C
    Klin Wochenschr; 1985 May; 63(10):433-59. PubMed ID: 2861306
    [No Abstract]   [Full Text] [Related]  

  • 67. [The effect of somatostatin on bronchial obstruction in carcinoid (author's transl)].
    Klapdor R; Lanser K; von Wichert P
    Prax Klin Pneumol; 1982 Apr; 36(4):202-5. PubMed ID: 6124963
    [No Abstract]   [Full Text] [Related]  

  • 68. Failure of halothane and ketamine to alleviate carcinoid syndrome-induced bronchospasm during anesthesia.
    Miller R; Boulukos PA; Warner RR
    Anesth Analg; 1980 Aug; 59(8):621-3. PubMed ID: 7190800
    [No Abstract]   [Full Text] [Related]  

  • 69. Intraoperative octreotide for refractory carcinoid-induced bronchospasm.
    Quinlivan JK; Roberts WA
    Anesth Analg; 1994 Feb; 78(2):400-2. PubMed ID: 8311295
    [No Abstract]   [Full Text] [Related]  

  • 70. [Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case].
    Festa V; Garrone C; Vietti Ramus G; Lisa F; Simone P; Scotti M; Cocchis D; Garrone GC
    Minerva Chir; 1989 May; 44(9):1429-33. PubMed ID: 2569698
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of somatostatin on bronchial constriction in a patient with carcinoid syndrome.
    Klapdor R
    N Engl J Med; 1980 Aug; 303(8):464. PubMed ID: 6104790
    [No Abstract]   [Full Text] [Related]  

  • 72. [Somatostatin analogs in the treatment of carcinoid syndrome: a case report and review of literature].
    Junik R; Kamińska A; Kamiński M; Ruprecht Z
    Pol Arch Med Wewn; 2003 Sep; 110(3):997-1001. PubMed ID: 14699693
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ectopic hormone production in cancer and its implication for basic research on abnormal growth.
    Gellhorn A
    Adv Intern Med; 1969; 15():299-316. PubMed ID: 4314455
    [No Abstract]   [Full Text] [Related]  

  • 74. Controlling the carcinoid syndrome.
    Hodgson HJ
    BMJ; 1988 Nov; 297(6658):1213-4. PubMed ID: 2905181
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.